We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Viewers Cautioned on Televised Medical Talk Show Recommendations

By HospiMedica International staff writers
Posted on 05 Jan 2015
Image: Study authors Mike Kolber, Christina Korownyck, and Mike Allan (Photo courtesy of the University of Alberta).
Image: Study authors Mike Kolber, Christina Korownyck, and Mike Allan (Photo courtesy of the University of Alberta).
A new study warns that the public should be skeptical of recommendations made on mainstream television medical talk shows, as they often lack adequate evidence or are contradicted by the best available evidence.

Researchers at the University of Alberta (Edmonton, Canada) chose two internationally syndicated medical talk shows to analyze: The Dr. Oz Show and The Doctors. Each show was recorded every day from January 2013 to April 2013. The researchers then randomly selected 40 episodes of each show and had two team members watch every episode independently, recording topics, recommendations made, and who was making the recommendations. Two other researchers also watched the episodes and review the recommendations, focusing on benefits mentioned, if the magnitude of the benefit was quantified, costs, and conflict of interest.

The researchers found evidence to support 54% of the 160 randomly selected recommendations (80 from each show). For The Dr. Oz Show, evidence supported 46%, contradicted 15%, and was not found for 39%. For The Doctors, evidence supported 63%, contradicted 14%, and was not found for 24%. Believable or somewhat believable evidence supported 33% of the recommendations on The Dr. Oz Show and 53% on The Doctors. The most common recommendation category on The Dr. Oz Show was dietary advice (39%) and on The Doctors was to consult a healthcare provider (18%).

Further findings included a specific benefit for 43% and 41% of the recommendations made on the shows respectively. The magnitude of benefit was described for 17% of the recommendations on The Dr. Oz Show and 11% on The Doctors. Disclosure of potential conflicts of interest accompanied only 0.4% of recommendations for both shows. The study was published in the Christmas edition of the British Medical Journal (BMJ), which was dedicated to media studies.

“Some patients come in and say 'I heard on Dr. Oz yesterday that we should all be doing this.' And then we're left scrambling in our office to try to find answers. It got us reflecting, what's being said there? What kinds of things are being recommended and what kind of information is being provided?” said lead author Christina Korownyk, MD, an associate professor in the department of family medicine. “Frequently you're not getting enough information and without doing the research you won't know if it's supported by evidence or not; the research supporting any of these recommendations is frequently absent, contradictory, or of poor quality.”

Related Links:

University of Alberta


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
New
Semi‑Automatic Defibrillator
Heart Save AED (ED300)

Channels

Surgical Techniques

view channel
Image: The novel approach combining MRI, fluid dynamics, and custom algorithms predicts brain cancer recurrence sites (photo courtesy of AdobeStock)

Novel Method Uses Interstitial Fluid Flow to Predict Where Brain Tumor Can Grow Next

Glioblastoma is one of the most aggressive brain cancers, with patients surviving on average only 15 months after diagnosis. Surgery and radiation can temporarily control the tumor, but the disease almost... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more